Home videos of cystic fibrosis patients using tobramycin inhalation powder: Relation of flow and cough

BACKGROUND: Many cystic fibrosis (CF) patients chronically infected with Pseudomonas aeruginosa are on maintenance tobramycin inhalation therapy. Cough is reported as a side effect of tobramycin inhalation powder (TIP) in 48% of the patients. Objectives of this study were to investigate the associat...

Descripción completa

Detalles Bibliográficos
Autores principales: Meerburg, Jennifer J., Albasri, Mehdi, van der Wiel, Els C., Andrinopoulou, Eleni‐Rosalina, van der Eerden, Menno M., Majoor, Christof J., Arets, Hubertus G.M., Heijerman, Harry G.M., Tiddens, Harm A.W.M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852538/
https://www.ncbi.nlm.nih.gov/pubmed/31393073
http://dx.doi.org/10.1002/ppul.24467

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852538/
https://www.ncbi.nlm.nih.gov/pubmed/31393073
http://dx.doi.org/10.1002/ppul.24467

Ejemplares similares